BioSpace News Archive

Namocell Inc. announced that it has entered into a collaboration with Takara Bio and HepaTx to use Namocell’s Single Cell Dispensers to perform single cell isolation on HepaTx’s unique hepatocyte-like cells developed from adipose tissue-derived stromal cells, and characterize them by single cell RNA-seq using Takara Bio’s SMART-Seq technology.

Relationships matter! Hence healthcare providers are leaning towards healthcare CRM.

The healthcare IT outsourcing market is featured by numerous mergers and acquisitions in order to gain substantial share in the global revenue of market.

Montis Biosciences announces its launch with €8,4 million in seed financing from an international investor syndicate to investigate interactions between perivascular macrophages and tumor vasculature.

The approval marks the first once-per-day 24-hour, intravenous COX-2 preferential NSAID, the company said.

Swelling can be dangerous as repetitive occasion of swelling at one particular part of the body can lead to hereditary angioedema.

Specialty clinics are seeing more and more cases of pregnancy related hypertension.

Unparalleled HealthTech forum helps drive and foster collaborations within the European healthcare and life sciences ecosystems to advance and accelerate patient solutions

“The good performance we saw in the third quarter has continued to further improve.

Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy